Johnson & Johnson (LON:0R34)

London flag London · Delayed Price · Currency is GBP · Price in USD
240.97
+1.01 (0.42%)
At close: Feb 11, 2026
Market Cap425.32B +46.1%
Revenue (ttm)69.85B +6.0%
Net Income19.88B +90.6%
EPS8.18 +90.5%
Shares Outn/a
PE Ratio21.40
Forward PE20.66
Dividend3.89 (1.62%)
Ex-Dividend DateNov 25, 2025
Volume5,897
Average Volume11,834
Open240.00
Previous Close239.96
Day's Range237.01 - 241.30
52-Week Range142.42 - 246.27
Betan/a
RSI80.21
Earnings DateJan 21, 2026

About Johnson & Johnson

Johnson & Johnson, together with its subsidiaries, engages in the research and development, manufacture, and sale of a range of products in the healthcare field worldwide. It operates in two segments, Innovative Medicine and MedTech. The Innovative Medicine segment offers products for various therapeutic areas, such as oncology, immunology, neuroscience, pulmonary hypertension, infectious diseases, and cardiovascular and metabolism distributed through retailers, wholesalers, distributors, hospitals, and healthcare professionals for prescription... [Read more]

Industry Pharmaceutical Preparations
Founded 1886
Employees 138,100
Stock Exchange London Stock Exchange
Ticker Symbol 0R34
Full Company Profile

Financial Performance

In 2025, Johnson & Johnson's revenue was $94.19 billion, an increase of 6.05% compared to the previous year's $88.82 billion. Earnings were $26.80 billion, an increase of 90.56%.

Financial numbers in USD Financial Statements